NLS Pharmaceutics Ltd

NCEL NASDAQ Healthcare & Biotech Europe
3.27 $
0.43 %

Pharmaceutical company developing innovative treatments for sleep-related conditions and other neurological disorders, combining drugs and medicinal technologies.

pharmaceuticals sleep disorders clinical research innovative drugs